Clinical Trials Browser

Completed × Interventional × Hand-Foot Syndrome × Clear all

Breast Neoplasms, Hand-Foot Syndrome

NCT05641246 2024-01-03

Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine

Phase 2 Completed

86 enrolled

Breast

Breast Neoplasms, Hand-Foot Syndrome

NCT01100463 2019-10-08

Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome

Phase 1/2 Completed

18 enrolled

Breast

Breast Neoplasms, Hyaline Fibromatosis Syndrome, Hand-Foot Syndrome

NCT03612011 2019-09-06

OCRP

Phase 3 Completed

72 enrolled

Neoplasms, Hand-Foot Syndrome

NCT02794493 2019-07-25

Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and/or Breast Cancer

Phase 3 Completed

156 enrolled

Hand-Foot Syndrome

NCT00992706 2019-05-15

F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer

Phase 3 Completed

91 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male, Hand-Foot Syndrome

NCT01918852 2018-03-14

SALTO

Phase 3 Completed

161 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms, Hand-Foot Syndrome

NCT00248248 2011-10-12

DOXIL for Consolidation Therapy in Ovarian Cancer.

Phase 2 Completed

45 enrolled

Gynecologic

Ovarian Neoplasms, Hand-Foot Syndrome

Clinical Trials

WIn-HFS

Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine

Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome

OCRP

Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and/or Breast Cancer

F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer

SALTO

DOXIL for Consolidation Therapy in Ovarian Cancer.